Fluorescein

Fluorescein

SCHEMBL136170

N=C=O.O=C1OC2(c3ccc(O)cc3Oc3cc(O)ccc32)c2ccccc21

nearest known ligand 0.87

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FTO Q9C0B1 9/20 0.87
MAPT P10636 4/20 0.87
MEN1 O00255 4/20 0.87
KMT2A Q03164 4/20 0.87
TDP1 Q9NUW8 3/20 0.87
HTT P42858 2/20 0.87
HPGD P15428 2/20 0.87
RECQL P46063 2/20 0.87
BLM P54132 2/20 0.87
PRMT1 Q99873 2/20 0.87
ACE2 Q9BYF1 2/20 0.87
CYP2C19 P33261 1/20 0.87
SMAD3 P84022 1/20 0.87
LMNA P02545 3/20 0.61
GPR55 Q9Y2T6 2/20 0.61
ALOX12 P18054 2/20 0.61
POLB P06746 1/20 0.61
NPSR1 Q6W5P4 1/20 0.61
ALDH1A1 P00352 3/20 0.56
USP2 O75604 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fluorescein SCHEMBL28575829 0.96 FTO (0.81) FTOMAPTMEN1KMT2ATDP1
Fluorescein SCHEMBL28125953 0.94 FTO (0.77) FTOMAPTMEN1KMT2ATDP1
Fluorescein SCHEMBL27822133 0.94 FTO (0.85) FTOMAPTMEN1KMT2ATDP1
Fluorescein SCHEMBL5664541 0.94 FTO (0.85) FTOMAPTMEN1KMT2ATDP1
Fluorescein SCHEMBL16545 0.94 FTO (0.85) FTOMAPTMEN1KMT2ATDP1
Fluorescein SCHEMBL30272223 0.93 FTO (1.00) FTOMAPTMEN1KMT2ATDP1
Fluorescein SCHEMBL29388667 0.93 FTO (1.00) FTOMAPTMEN1KMT2ATDP1
Fluorescein SCHEMBL16533 0.93 FTO (1.00) FTOMAPTMEN1KMT2ATDP1
Fluorescein SCHEMBL29371199 0.93 FTO (1.00) FTOMAPTMEN1KMT2ATDP1
Fluorescein SCHEMBL3645090 0.93 FTO (1.00) FTOMAPTMEN1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1539 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119710095-A Composition, kit and method for detecting HPV genotype 浙江清华长三角研究院 2025-03-28 CN claimed
CN-119530432-A System, kit and method for detecting fusarium graminearum of bakanae disease germ of rice 上海市农业科学院 2025-02-28 CN claimed
CN-114428070-B Molecularly imprinted fluorescent nanoparticle for detecting gram-negative bacteria and preparation method thereof 南京师范大学 2024-05-17 CN claimed
EP-3554526-B1 LUTEINIZING HORMONE-RELEASING HORMONE RECEPTOR (LHRH-R) CONJUGATES AND USES THEREOF PURDUE RESEARCH FOUNDATION (US) 2024-05-08 EP claimed
US-11883498-B2 Luteinizing hormone-releasing hormone receptor (LHRH-R) conjugates and uses thereof PURDUE RESEARCH FOUNDATION (US) 2024-01-30 US claimed
CN-111936641-B Compositions and methods for detecting human papillomavirus 杭州诺辉健康科技有限公司 2022-07-15 CN claimed
CN-114428070-A Molecularly imprinted fluorescent nanoparticle for detecting gram-negative bacteria and preparation method thereof 南京师范大学 2022-05-03 CN claimed
US-20220090218-A1 COMPOSITIONS AND METHODS FOR DETECTING HUMAN PAPILLOMAVIRUS HANGZHOU NEW HORIZON HEALTH TECHNOLOGY CO. LTD. (CN) 2022-03-24 US claimed
EP-3906325-A1 COMPOSITIONS AND METHODS FOR DETECTING HUMAN PAPILLOMAVIRUS Hangzhou New Horizon Health Technology Co., Ltd. (CN) 2021-11-10 EP claimed
US-20210330516-A1 APPARATUS, SYSTEM, AND METHOD FOR DETECTING A TARGET SUBSTANCE UNDERCOVER COLORS INC (US) 2021-10-28 US claimed
WO-2010120905-A2 NOVEL NANO-PROBES FOR MOLECULAR IMAGING AND TARGETED THERAPY OF DISEASES BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2010-10-21 WO claimed
US-20100093994-A1 REPARATION METHOD OF AN AMINO LINKER OLIGONUCLEOTIDES AND LABELED-LINKER OLIGONUCLEOTIDE THEREFROM POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) 2010-04-15 US claimed
US-20080292545-A1 Functionalized Encoded Apoferritin Nanoparticles and Processes for Making and Using Same BATTELLE MEMORIAL INSTITUTE 2008-11-27 US claimed
US-20060115896-A1 Diagnostic test for west nile virus HEALTH RESEARCH, INC. 2006-06-01 US claimed
EP-0851230-B1 Method and Apparatus for Immunoassay using Fluorescent Induced Surface Plasma Emission DIAGNOSTIC PRODUCTS CORP (US) 2003-03-19 EP claimed
US-5776785-A Method and apparatus for immunoassay using fluorescent induced surface plasma emission DIAGNOSTIC PRODUCTS CORPORATION (US) 1998-07-07 US claimed
EP-0851230-A1 Method and Apparatus for Immunoassay using Fluorescent Induced Surface Plasma Emission DIAGNOSTIC PRODUCTS CORPORATION (US) 1998-07-01 EP claimed
US-4491634-A PEROXIDE, CHLORAMINE, FLUORESCEIN FRENZEL BERND 1985-01-01 US claimed
US-4455380-A Process for determining tumor-associated glycolinkage OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1984-06-19 US claimed
US-4433060-A QUANTITATIVE OR QUALITATIVE ANALYSIS BY COMPLEXING OF ANTIGEN/ANTIBODY AND CHEMILUMINESCENT LABEL FRENZEL BERND (DE) 1984-02-21 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11883498-B2 Luteinizing hormone-releasing hormone receptor (LHRH-R) conjugates and uses thereof GNRHR, LHCGR, GHRHR FTO 2148/4885MAPT 2652/4885MEN1 324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.